Journal of Clinical Medicine·Nov 18Body Mass Index and LDL Cholesterol in Relation to PREVENT-HF Risk and Vascular Phenotypes in Treated HypertensionCross-sectional study of 158 peopleLDL cholesterolPaper
International Journal of Molecular Sciences·Nov 18PCSK9 Inhibition in Transition: From Established Treatments to Emerging Therapeutic ApproachesReviewInterventionsPaper
Diabetes Therapy·Nov 18Weighted Cumulative Exposure of HbA1c and LDL-C and All-Cause Mortality in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort StudyCohort study of 7,978 peopleChronic kidney diseasePaper
Healthcare·Nov 18Development and Validation of a TyG Index Based Model for Predicting Metabolic Syndrome Risk in a Western Chinese Plateau PopulationCohort study of 1,304 peopleMetabolic syndromePaper
Diabetology & Metabolic Syndrome·Nov 18The association between a novel visceral lipoprotein risk index and new-onset diabetes in middle-aged and older Chinese adultsCohort study of 7,559 peopleIncident diabetesPaper
Annals of Medicine·Nov 17Sex-stratified associations between the triglyceride-glucose index and urinary AD7c-NTP levels in adults: a cross-sectional studyCross-sectional study of 4,879 peopleTriglyceride-glucose indexPaper
Heart Views·Nov 17Prescribed But Not Pursued: Low-density Lipoprotein Cholesterol Target Attainment, Monitoring gaps, and Therapeutic Inertia after Percutaneous Coronary Intervention in BahrainCohort study of 204 peoplePopulationsPaper
Annals of African Medicine·Nov 17Association of Betel Quid Chewing with Anthropometric Parameters and Lipid Profile in Type-2 Diabetes Mellitus PatientsCross-sectional study in peopleType 2 diabetesPaper
Chinese General Practice·Nov 17The Influence of Intensified Lifestyle Intervention on the Quality of Life of Elderly Patients with Non-valvular Persistent Atrial Fibrillation in Xinjiang RegionRandomized trial in 100 peopleInterventionsPaper
Nutrients·Nov 17β-Glucan Supplementation in Chronic Disease Management: A Systematic Review of Randomized Controlled TrialsSystematic review of randomized trialsInterventionsPaper
Nutrition, Metabolism, and Cardiovascular Diseases·Nov 17Intensive early and sustained lowering of LDL-C and inflammation after index PCI and Cardiovascular OutcomesCohort study in peoplePopulationsPaper
Clinical Laboratory·Nov 16Revisiting the Triglyceride Threshold for LDL-C Calculation Considering Measurement UncertaintyCross-sectional study of 122,639 peopleTriglyceridePaper
Cardiology in Review·Nov 16Efficacy and Safety of the Oral PCSK9 Inhibitor Enlicitide in Adults With Dyslipidemia: A GRADE-Assessed Meta-Analysis of Randomized Controlled Trials With Dose–Response Meta-RegressionMeta-analysis of randomized trialsEnlicitidePaper
Frontiers in Pharmacology·Nov 16Updated evidence for oral PCSK9 inhibitors: a drug-specific, GRADE-assessed systematic review and meta-analysis of phase 3 enlicitide trialsMeta-analysis of randomized trialsEnlicitidePaper
Journal of Cardiology Cases·Nov 16Graves' disease with unrecognized symptoms detected by NT-proBNP screening and longitudinal lipid profile assessmentCase reportNT-proBNPPaper
International Journal of Cardiology Cardiovascular Risk and Prevention·Nov 16Personalizing postpartum cardiovascular prevention after preeclampsia: Is routine statin therapy justified in normotensive survivors? A critical narrative reviewReviewStatinsPaper
Journal of Atherosclerosis and Thrombosis·Nov 16Physician-Pharmacist PBPM for Intensive Lipid Management After Acute Myocardial InfarctionCohort study of 438 peopleAcute myocardial infarctionPaper
Frontiers in Pharmacology·Nov 16The Role and Status of Atorvastatin in the Cholesterol and Inflammation Dual-Target Era: A narrative reviewAccepted, not yet published: reviewAtorvastatinPaper
medRxiv·Nov 16Direction of apoB/LDL-C Discordance and Systemic Inflammation in U.S. AdultsPreprint: cross-sectional study of 2,226 peopleBiomarkersPaper
Sport Sciences for Health·Nov 15Cardiovascular disease risk factors as key indicator of heart rate variability in firefightersCross-sectional study of 309 peoplePopulationsPaper
Scientific Reports·Nov 14A randomized controlled trial of resistance training combined with breathing retraining on cardiometabolic and pulmonary outcomesin overweight young womenRandomized trial in 28 peopleOverweightPaper
Diabetology & Metabolic Syndrome·Nov 14Mazdutide for weight management in adults with overweight or obesity: an endpoint-specific systematic review and meta-analysis of randomized controlled trialsMeta-analysis of randomized trialsMazdutidePaper
Expert Review of Neurotherapeutics·Nov 14Lipid-lowering therapy for secondary stroke prevention beyond statin monotherapy: a mechanism-informed approach across drug classes and stroke subtypesReviewStatinsPaper
JACC Asia·Nov 14Remnant Cholesterol and Atherosclerotic Risk in Chronic Kidney DiseaseMeta-analysis of observational studiesVLDL cholesterolPaper
BMC Geriatrics·Nov 14Remnant cholesterol combined with LDL-C and risk of major adverse cardiovascular events in elderly hypertensive Patients: A retrospective cohort studyCohort study of 847 peopleRemnant cholesterolPaper
Neurological Sciences·Nov 14In-hospital inclisiran for early LDL-C lowering after atherosclerotic ischemic stroke: an observational pilot studyCohort study of 15 peopleInclisiranPaper
Clinical Nutrition·Nov 14Effects of Fish Oil Intervention on Residual Risk of Cardiovascular Disease in Middle-Aged and Elderly People: A Randomized Controlled TrialRandomized trial in 240 peopleFish oilPaper
Frontiers in Pharmacology·Nov 13Cardiometabolic Benefits Beyond Glycemia: A Propensity-Matched Cohort Study of Adding a GLP-1 Receptor Agonist to SGLT-2 Inhibitor Therapy in Type 2 DiabetesAccepted, not yet published: cohort study of 523 peopleGLP-1 receptor agonists + SGLT2 inhibitorsPaper
Archives of Environmental & Occupational Health·Nov 13Ambient particulate matter and blood lipids: Effect modification by dyslipidemiaCross-sectional study in peopleDyslipidemiaPaper
American Heart Journal Plus·Nov 13Systematic review and network meta-analysis: Comparison and selection of lipid-lowering strategies for improving atherosclerotic plaque vulnerabilityMeta-analysis of randomized trialsAtherosclerosisPaper